...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Thyroid Function among Children with Iron Deficiency Anaemia: Pre and Post Iron Replacement Therapy
【24h】

Thyroid Function among Children with Iron Deficiency Anaemia: Pre and Post Iron Replacement Therapy

机译:缺铁性贫血儿童的甲状腺功能:铁替代治疗前后

获取原文
           

摘要

Metabolism of thyroid hormones and iron is quite interdependent. Data indicates that Iron Deficiency (ID) could impair thyroid metabolism.Aim: To investigate the possible occurrence of thyroid dysfunction among children with isolated Iron Deficiency Anaemia (IDA) of various severities, and test if the oral iron replacement therapy alone can reverse the associated thyroid function disturbances, if present or additional therapies are required.Materials and Methods: This prospective study was carried out on 60 children selected from the attendants to the outpatient paediatric clinics of Al-Azhar University, Assiut and Qena university hospitals, Egypt, in addition to 60 controls. Complete blood count, thyroid profile, ferritin, iron, Total Iron Binding Capacity (TIBC), Transferrin Saturation% (TFS%), unsaturated iron binding capacity and Urinary Iodine Excretion (UIE) were assessed in the studied groups at baseline, then haemoglobin level and thyroid profile repeated among the studied patients after three months of oral iron supplementation therapy. Thyroid profile and ferritin were measured using commercially available Enzyme Linked Immunosorbent Assay (ELISA) kits; while, iron, TIBC and UIE were measured using colorimetric methods.Results: Significant higher serum Thyroid Stimulating Hormone (TSH) levels with significant lower serum levels of Free Triiodothyronine (FT3) and Free Thyroxine (FT4) among patients versus controls (p<0.001 for all). Significant positive correlation between serum iron and FT3 (r=0.284, p<0.05) with significant negative correlations between TSH versus both serum iron (r=-0.635, p<0.001) and ferritin (r=-0.342, p<0.01). Significant decrease in the serum levels of TSH, with significant increase in the serum levels of FT3 and FT4 (p<0.001 for all) to euthyroid status following oral iron replacement therapy.Conclusion: Subclinical or primary hypothyroidism can occur among children suffering from moderate to severe IDA, which is reversible following oral iron replacement therapy only, without need to add thyroid replacement therapy.
机译:甲状腺激素和铁的代谢是相互依存的。数据表明铁缺乏症(ID)可能会损害甲状腺代谢。目的:调查患有各种严重程度的孤立铁缺乏症贫血(IDA)的儿童中甲状腺功能障碍的可能发生,并测试口服铁替代疗法是否可以单独治疗材料与方法:这项前瞻性研究是从Al-Azhar大学,Assiut和Qena大学门诊儿科门诊的60名儿童中进行的前瞻性研究埃及的医院,以及60个控制点。在基线时评估研究组的全血细胞计数,甲状腺谱,铁蛋白,铁,总铁结合能力(TIBC),转铁蛋白饱和度%(TFS%),不饱和铁结合能力和尿碘排泄(UIE),然后评估血红蛋白水平在接受口服铁补充治疗三个月后,研究患者中的甲状腺和甲状腺形态重复。使用可商购的酶联免疫吸附测定(ELISA)试剂盒测量甲状腺分布和铁蛋白。结果:患者与对照组的血清甲状腺刺激激素(TSH)水平明显升高,而游离三碘甲状腺素(FT3)和游离甲状腺素(FT4)的血清水平明显降低(对于所有p <0.001)。血清铁和FT3之间显着正相关(r = 0.284,p <0.05),而TSH与血清铁(r = -0.635,p <0.001)和铁蛋白(r = -0.342,p <0.01)显着负相关。口服铁替代治疗后甲状腺功能正常状态下,TSH的血清水平显着降低,而FT3和FT4的血清水平显着升高(对于所有患者,p <0.001)。从中度至重度IDA,仅在口服铁替代疗法后可逆,而无需增加甲状腺替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号